119 related articles for article (PubMed ID: 16135085)
1. Proliferation of microglial cells induced by 1-methyl-4-phenylpyridinium in mesencephalic cultures results from an astrocyte-dependent mechanism: role of granulocyte macrophage colony-stimulating factor.
Henze C; Hartmann A; Lescot T; Hirsch EC; Michel PP
J Neurochem; 2005 Nov; 95(4):1069-77. PubMed ID: 16135085
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte colony-stimulating factor is not protective against selective dopaminergic cell death in vitro.
Henze C; Lescot T; Traver S; Salthun-Lassalle B; Hirsch EC; Michel PP; Hartmann A
Neurosci Lett; 2005 Jul 22-29; 383(1-2):44-8. PubMed ID: 15936509
[TBL] [Abstract][Full Text] [Related]
3. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.
Park TH; Mytilineou C
Brain Res; 1992 Dec; 599(1):83-97. PubMed ID: 1362921
[TBL] [Abstract][Full Text] [Related]
4. Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures.
McNaught KS; Jenner P
J Neurochem; 1999 Dec; 73(6):2469-76. PubMed ID: 10582607
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
[TBL] [Abstract][Full Text] [Related]
6. Transient receptor potential vanilloid subtype 1 contributes to mesencephalic dopaminergic neuronal survival by inhibiting microglia-originated oxidative stress.
Park ES; Kim SR; Jin BK
Brain Res Bull; 2012 Nov; 89(3-4):92-6. PubMed ID: 22796104
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 9 prevents MPP+-induced death of dopaminergic neurons and is involved in melatonin neuroprotection in vivo and in vitro.
Huang JY; Hong YT; Chuang JI
J Neurochem; 2009 Jun; 109(5):1400-12. PubMed ID: 19476551
[TBL] [Abstract][Full Text] [Related]
8. The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.
Lannuzel A; Michel PP; Höglinger GU; Champy P; Jousset A; Medja F; Lombès A; Darios F; Gleye C; Laurens A; Hocquemiller R; Hirsch EC; Ruberg M
Neuroscience; 2003; 121(2):287-96. PubMed ID: 14521988
[TBL] [Abstract][Full Text] [Related]
9. Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons.
Bilsland J; Roy S; Xanthoudakis S; Nicholson DW; Han Y; Grimm E; Hefti F; Harper SJ
J Neurosci; 2002 Apr; 22(7):2637-49. PubMed ID: 11923429
[TBL] [Abstract][Full Text] [Related]
10. High yield primary microglial cultures using granulocyte macrophage-colony stimulating factor from embryonic murine cerebral cortical tissue.
Yu AC; Neil SE; Quandt JA
J Neuroimmunol; 2017 Jun; 307():53-62. PubMed ID: 28495139
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
Meuer K; Pitzer C; Teismann P; Krüger C; Göricke B; Laage R; Lingor P; Peters K; Schlachetzki JC; Kobayashi K; Dietz GP; Weber D; Ferger B; Schäbitz WR; Bach A; Schulz JB; Bähr M; Schneider A; Weishaupt JH
J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor antibody suppresses microglial activity: implications for anti-inflammatory effects in Alzheimer's disease and multiple sclerosis.
Reddy PH; Manczak M; Zhao W; Nakamura K; Bebbington C; Yarranton G; Mao P
J Neurochem; 2009 Dec; 111(6):1514-28. PubMed ID: 19840215
[TBL] [Abstract][Full Text] [Related]
13. Regional microglia are transcriptionally distinct but similarly exacerbate neurodegeneration in a culture model of Parkinson's disease.
Kostuk EW; Cai J; Iacovitti L
J Neuroinflammation; 2018 May; 15(1):139. PubMed ID: 29751760
[TBL] [Abstract][Full Text] [Related]
14. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
Vaglini F; Pardini C; Cavalletti M; Maggio R; Corsini GU
Brain Res; 1996 Nov; 741(1-2):68-74. PubMed ID: 9001706
[TBL] [Abstract][Full Text] [Related]
15. The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures.
Michel PP; Agid Y
Brain Res; 1992 Dec; 597(2):233-40. PubMed ID: 1361874
[TBL] [Abstract][Full Text] [Related]
16. GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures.
Lee SC; Liu W; Brosnan CF; Dickson DW
Glia; 1994 Dec; 12(4):309-18. PubMed ID: 7890333
[TBL] [Abstract][Full Text] [Related]
17. TGF-β1 Neuroprotection via Inhibition of Microglial Activation in a Rat Model of Parkinson's Disease.
Chen X; Liu Z; Cao BB; Qiu YH; Peng YP
J Neuroimmune Pharmacol; 2017 Sep; 12(3):433-446. PubMed ID: 28429275
[TBL] [Abstract][Full Text] [Related]
18. Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.
Moldzio R; Pacher T; Krewenka C; Kranner B; Novak J; Duvigneau JC; Rausch WD
Phytomedicine; 2012 Jun; 19(8-9):819-24. PubMed ID: 22571976
[TBL] [Abstract][Full Text] [Related]
19. Stage-dependent vulnerability of fetal mesencephalic neuroprogenitors towards dopaminergic neurotoxins.
Sabolek M; Mieskes I; Lenk T; Lehmensiek V; Hermann A; Schwarz J; Storch A
Neurotoxicology; 2008 Jul; 29(4):714-21. PubMed ID: 18513801
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (Mpp+) towards dopaminergic mesencephalic neurones in primary culture.
Callier S; Le Saux M; Lhiaubet AM; Di Paolo T; Rostène W; Pelaprat D
J Neurochem; 2002 Jan; 80(2):307-16. PubMed ID: 11902121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
